Skip to main content
C
CorpDigest
Search

DaVita Inc.

Kidney care and dialysis servicesFounded 1979
Reviewed by Swet Parvadiya
Company data updated: October 2026

Acquisitions

DaVita Acquisitions

3

Major Deals Covered

$7.5B

Disclosed Deal Value

What are DaVita's biggest acquisitions?

DaVita's largest disclosed acquisition here is HealthCare Partners for $4.4B in 2012. This page covers 3 major deals from 2005 to 2012, each with its price where disclosed and the reason behind it.

Major deals covered
3
Largest deal
HealthCare Partners ($4.4B)
First deal
2005
Most recent
2012
CompanyYearPricePurpose
Gambro Healthcare (US dialysis business)2005$3.0BDaVita bought Gambro Healthcare's U.S. dialysis business for about $3.05 billion to gain national scale against Fresenius Medical Care.
HealthCare Partners2012$4.4BDaVita acquired HealthCare Partners to diversify beyond dialysis into physician group management and integrated care. HealthCare Partners operated medical groups in California, Colorado, Florida, Nevada, New Mexico, and Washington, serving approximately 1.7 million patients.
Various International Dialysis Providers—UndisclosedDaVita has acquired dialysis providers in multiple international markets including Brazil, Colombia, Chile, Ecuador, Malaysia, and Saudi Arabia to expand its global footprint. These acquisitions target markets with underdeveloped dialysis infrastructure and growing demand.
What companies has DaVita bought?
Major acquisitions by DaVita documented here include HealthCare Partners (2012), Gambro Healthcare (US dialysis business) (2005) and Various International Dialysis Providers.
What is DaVita's most recent acquisition?
The most recent DaVita acquisition documented here is HealthCare Partners, in 2012, for $4.4B.

HealthCare Partners

2012

$4.4B

Why

DaVita acquired HealthCare Partners to diversify beyond dialysis into physician group management and integrated care. HealthCare Partners operated medical groups in California, Colorado, Florida, Nevada, New Mexico, and Washington, serving approximately 1.7 million patients.

Impact

HealthCare Partners added physician-group revenue in California, Nevada, and Florida, but its economics differed from dialysis and it later required goodwill impairments.

Outcome

DaVita sold DaVita Medical Group to Optum in June 2019 for about $4.34 billion, slightly below the 2012 purchase price, and refocused on kidney care.

Source →

Gambro Healthcare (US dialysis business)

2005

$3.0B

Why

DaVita bought Gambro Healthcare's U.S. dialysis business for about $3.05 billion to gain national scale against Fresenius Medical Care.

Impact

The deal added more than 500 outpatient centers and made DaVita one of the two dominant U.S. dialysis providers. It was financed mainly with debt, and the FTC required clinic divestitures.

Outcome

Gambro's clinics remain a core part of DaVita's U.S. network and its purchasing and operating scale.

Source →

Various International Dialysis Providers

Why

DaVita has acquired dialysis providers in multiple international markets including Brazil, Colombia, Chile, Ecuador, Malaysia, and Saudi Arabia to expand its global footprint. These acquisitions target markets with underdeveloped dialysis infrastructure and growing demand.

Impact

International operations reached 595 outpatient centers in 14 countries by June 30, 2026.

Outcome

International expansion diversifies DaVita beyond U.S. reimbursement, but each market brings distinct regulatory and payer risks.

Source →

DaVita Inc.'s Growth & Acquisition Strategy

DaVita's strategy is to grow earnings faster than revenue. It raises revenue per treatment, controls patient care costs, and buys back shares with free cash flow. It also expands international clinics (595 centers in 14 countries by mid-2026), grows home dialysis, and scales Integrated Kidney Care risk contracts that pay for slowing disease progression and reducing hospitalizations. Through Mozarc Medical, its kidney-technology joint venture with Medtronic, it invests in new dialysis devices.

How DaVita Inc. Makes Money

DaVita is paid per dialysis treatment. Most patients receive in-center hemodialysis about three times a week, while others dialyze at home with DaVita training and support. Medicare's bundled ESRD payment covers the majority of patients, but commercial insurers pay substantially more per treatment, so payer mix is the key profit driver. In Q2 2026 U.S. revenue per treatment was $415.87 against patient care costs of $277.40. Many clinics are joint ventures with nephrology practices, and the Integrated Kidney Care (IKC) unit takes risk-based contracts, including the CMS Kidney Care Choices model, where DaVita shares in savings when total cost of care falls.

DaVita Acquisitions FAQ

What was the significance of the $3.05 billion acquisition of Gambro Healthcare in 2005?

In October 2005 DaVita completed its roughly $3.05 billion purchase of Gambro Healthcare's U.S. dialysis business. The deal added more than 500 centers and established DaVita as one of the two dominant U.S. providers.

Why did DaVita acquire Healthcare Partners for $4.42 billion in 2012?

In November 2012, DaVita acquired HealthCare Partners for $4.42 billion, expanding into comprehensive primary care and physician networks (forming DaVita Medical Group), which it successfully operated before selling to UnitedHealth/Optum in 2019 for $4.3 billion.

What was the impact of selling DaVita Medical Group to Optum?

Selling DaVita Medical Group to Optum in June 2019 for about $4.34 billion ended DaVita's physician-group detour and funded share repurchases and debt reduction.

How does DaVita evaluate international dialysis clinic acquisitions?

DaVita evaluates international clinic acquisitions in countries with expanding middle-class populations, established private health insurance, and supportive public reimbursement (such as Brazil, Colombia, and Saudi Arabia).

What future M&A criteria guide DaVita's strategic capital deployment?

DaVita pursues disciplined bolt-on clinic acquisitions, joint-venture nephrology partnerships, digital remote patient monitoring platforms, and home dialysis technologies that directly improve patient longevity and quality of life.

Did DaVita sell its medical group?

Yes, in a massive strategic pivot, DaVita sold its entire primary care physician network (DaVita Medical Group) to UnitedHealth's Optum division for $4.3 billion in 2019, deciding to refocus 100% on its core kidney dialysis monopoly.

Related M&A Histories

Compare corporate acquisition records, deal values, and strategic targets

Competitor

Unitedhealth

View M&A Histories
Competitor

Cvs Health

View M&A Histories
Competitor

Hca Healthcare

View M&A Histories
Competitor

Tenet Healthcare

View M&A Histories
Competitor

Elevance Health

View M&A Histories
Competitor

Berkshire Hathaway

View M&A Histories

Explore DaVita

Core profile pages, founders and related research hubs for this company.

Content is for informational purposes only. Not financial advice. Data sourced from SEC filings, annual reports, and public records. See our full disclaimer and methodology.